This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.
The New England journal of medicine, 393(18), 1796-1806
Citation
Wharton, Sean; Aronne, Louis J; Stefanski, Adam; Alfaris, Nasreen F; Ciudin, Andreea; Yokote, Koutaro; Halpern, Bruno; Shukla, Alpana P; Zhou, Chunmei; Macpherson, Lisa; Allen, Sheryl E; Ahmad, Nadia N; Klise, Suzanne R. (2025). Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment.. The New England journal of medicine, 393(18), 1796-1806. https://doi.org/10.1056/NEJMoa2511774